Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MetasTx
AddedFeb 17, 2024
UpdatedJun 18, 2026
MetasTx

MetasTx

Pre-Seed

MetasTx: Innovating prostate cancer treatments since 2021, focusing on metastasis prevention.

HQ
Basking Ridge, NJ, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded in 2021, MetasTx is dedicated to innovating treatments for prostate cancer, specifically focusing on preventing and treating metastasis without impacting the Androgen System. The company's core mission is to develop novel therapeutics that address the critical challenge of cancer spread, aiming to transform the future of cancer treatment. MetasTx's market focus is on providing advanced medical solutions for prostate cancer patients, leveraging cutting-edge scientific research to achieve their vision.

MetasTx has attracted notable investors and experts in the oncology field, contributing to its rapid progress and credibility. The company has achieved significant milestones in its research pipeline, showcasing promising results in preclinical trials. By addressing the unmet needs in prostate cancer treatment, MetasTx is making a substantial impact on the medical community and improving patient outcomes.

MetasTx - Similar Companies

MedicaMetrix logo

MedicaMetrix

medicametrix.com

Novasenta logo

Novasenta

novasenta.com

Metaclipse Therapeutics logo

Metaclipse Therapeutics

ImmunoMet Therapeutics logo

ImmunoMet Therapeutics

immunomet.com

Palm Therapeutics logo

Palm Therapeutics

EtiraRx logo

EtiraRx

etirarx.com

Oncternal Therapeutics logo

Oncternal Therapeutics

oncternal.com

LifeBridge Innovations logo

LifeBridge Innovations

Metfora logo

Metfora

metfora.com

Window Therapeutics logo

Window Therapeutics

windowtx.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

OncoSpherix logo

OncoSpherix

oncospherix.com

Sporos Bioventures logo

Sporos Bioventures

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Faeth Therapeutics logo

Faeth Therapeutics

MetasTx - Quick Facts

Who are MetasTx's competitors?

Companies similar to MetasTx include MedicaMetrix, Novasenta, Metaclipse Therapeutics and ImmunoMet Therapeutics.

When was MetasTx founded?

MetasTx was founded in 2021.

Where is MetasTx's headquarters located?

MetasTx's headquarters is located in Basking Ridge, NJ, US.

When was MetasTx's last funding round?

MetasTx's most recent funding round was for $100k (USD) in December 2023.

How much has MetasTx raised to-date?

As of Dec 6, 2023, MetasTx has raised a total of $100k (USD).

How many employees does MetasTx have?

MetasTx has 3 employees as of Feb 4, 2024.

MetasTx - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations